Premium
Phio Pharmaceuticals Corporation (PHIO)
NASDAQ
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs. The company's pipelin... Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs. The company's pipeline products include PH-762, PH-804, PH-790, and others. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.3599 | -15.9247787611 | 2.26 | 2.27 | 1.88 | 485000 | 2.03698066 | CS |
| 4 | 0.2101 | 12.4319526627 | 1.69 | 9.79 | 1.61 | 20543500 | 5.70863504 | CS |
| 12 | -0.5499 | -22.4448979592 | 2.45 | 9.79 | 1.53 | 7097420 | 5.51706581 | CS |
| 26 | -0.9999 | -34.4793103448 | 2.9 | 9.79 | 1.53 | 3132409 | 5.49059934 | CS |
| 52 | -3.4999 | -64.812962963 | 5.4 | 10.35 | 1.53 | 1700593 | 5.62998584 | CS |
| 156 | -95.2999 | -98.0451646091 | 97.2 | 261.36 | 1.53 | 1085489 | 65.46209743 | CS |
| 260 | -859.9399 | -99.7795298431 | 861.84 | 889.92 | 1.53 | 944535 | 131.23060811 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
